One Put, One Call Option To Know About For Johnson & Johnson (JNJ)
Selling a put does not give an investor access to JNJ's upside potential the way owning shares would, because the put seller only ends up owning shares in the scenario where the contract is exercised. So unless Johnson & Johnson sees its shares decline 1.6% and the contract is exercised (resulting in a cost basis of $97.57 per share before broker commissions, subtracting the $1.43 from $99), the only upside to the put seller is from collecting that premium for the 11.5% annualized rate of return.
Worth considering, is that the annualized 11.5% figure actually exceeds the 2.8% annualized dividend paid by Johnson & Johnson by 8.7%, based on the current share price of $100.55. And yet, if an investor was to buy the stock at the going market price in order to collect the dividend, there is greater downside because the stock would have to lose 1.56% to reach the $99 strike price.